Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 2, Pages 159-177
Publisher
Informa Healthcare
Online
2014-12-13
DOI
10.1517/14656566.2015.993381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched case-control study
- (2014) Jin Young Ahn et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae in Community Hospitals
- (2014) Grace C. Lee et al. ANNALS OF PHARMACOTHERAPY
- Pharmacodynamic profile of commonly utilised parenteral therapies against meticillin-susceptible and meticillin-resistant Staphylococcus aureus collected from US hospitals
- (2014) Seth T. Housman et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort
- (2014) L. E. Lopez-Cortes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-ProducingEscherichia Coli-Related Complicated Lower Urinary Tract Infection
- (2014) S. Senol et al. JOURNAL OF CHEMOTHERAPY
- Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis
- (2014) Courtney A Reynolds et al. Antimicrobial Resistance and Infection Control
- Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia
- (2013) Yu-long Zheng et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge
- (2013) Frederic S. Zimmerman et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection
- (2013) Anthony M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
- (2013) Helen Giamarellou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
- (2013) David Oldach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone
- (2013) Thomas J. Dilworth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
- (2013) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin non-susceptible Staphylococcus aureus at a US medical centre
- (2013) A. Velazquez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization
- (2013) A.A.Y. Cheah et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011
- (2013) Sam K. Bouchillon et al. CLINICAL THERAPEUTICS
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli
- (2013) George G. Zhanel et al. DRUGS
- Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013
- (2013) J Decousser et al. Eurosurveillance
- Prevalence and Risk Factors for Acquisition of Carbapenem-Resistant Enterobacteriaceae in the Setting of Endemicity
- (2013) Mahesh Swaminathan et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial
- (2013) Christopher Lucasti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010
- (2012) William R. Jarvis et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia
- (2012) Jennifer H. Han et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
- (2012) Elizabeth A. Neuner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid Surveillance Results for the United States: LEADER Surveillance Program 2011
- (2012) R. K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Clinical Characteristics and Outcomes Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant E. faecium Bacteremia
- (2012) Kayoko Hayakawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition
- (2012) Eva Morales et al. BMC HEALTH SERVICES RESEARCH
- Klebsiella ESBL bacteremia-mortality and risk factors
- (2012) Felipe Francisco Tuon et al. Brazilian Journal of Infectious Diseases
- AWARE Ceftaroline Surveillance Program (2008–2010): Trends in Resistance Patterns Among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
- (2012) Michael A. Pfaller et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit
- (2012) F. Sbrana et al. CLINICAL INFECTIOUS DISEASES
- Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters
- (2012) Nan-Yao Lee et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
- (2012) B.Y. Lee et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
- (2012) José A. Vazquez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010
- (2012) Anne Marie Queenan et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship
- (2012) Dror Marchaim et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Nosocomial Transmission of New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae in Toronto, Canada
- (2012) Christopher F. Lowe et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection
- (2012) Meltem Isikgoz Tasbakan et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The emerging problem of linezolid-resistant Staphylococcus
- (2012) B. Gu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Strains Containing New Delhi Metallo-Beta-Lactamase Isolated from Two Patients in Vietnam: Table 1
- (2012) Tran Huy Hoang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Carbapenem resistance in Enterobacteriaceae: here is the storm!
- (2012) Patrice Nordmann et al. TRENDS IN MOLECULAR MEDICINE
- The relationship between pneumococcal serotypes and antibiotic resistance
- (2012) Jae-Hoon Song et al. VACCINE
- Clinical Outcomes of Tigecycline in the Treatment of Multidrug-ResistantAcinetobacter baumanniiInfection
- (2012) Jung Ar Shin et al. YONSEI MEDICAL JOURNAL
- Treatment of Klebsiella Pneumoniae Carbapenemase (KPC) infections: a review of published case series and case reports
- (2012) Grace C Lee et al. Annals of Clinical Microbiology and Antimicrobials
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Delhi metallo- -lactamase-1 in Enterobacteriaceae: emerging resistance
- (2011) D. R. Pillai et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2011) Xavier Bertrand et al. CLINICAL THERAPEUTICS
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
- (2011) Elizabeth A. Neuner et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
- (2011) Mini Kamboj et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Impact of a clonal outbreak of extended-spectrum -lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK
- (2011) D. P. Webster et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo- -lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis
- (2011) N. R. H. Stone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections
- (2011) Sebastiaan J. van Hal et al. PLoS One
- Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient
- (2011) Jaime Mei Fong Chien et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- The emerging NDM carbapenemases
- (2011) Patrice Nordmann et al. TRENDS IN MICROBIOLOGY
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Pharmacodynamic Approaches to Optimizing Beta-Lactam Therapy
- (2010) Jared L. Crandon et al. CRITICAL CARE CLINICS
- Methicillin-resistant Staphylococcus aureus resistance to non–β-lactam antimicrobials in the United States from 1996 to 2008
- (2010) Jose Bordon et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage
- (2010) Mathias W. Pletz et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- AmpC induction by ceftaroline
- (2010) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of NDM-1-producing Enterobacteriaceae in Norway
- (2010) Ørjan Samuelsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum β-lactamase (ESBL) and non-ESBL Producing Escherichia coli
- (2010) Chia-Jung Hsieh et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Costs Attributable to Healthcare-Acquired Infection in Hospitalized Adults and a Comparison of Economic Methods
- (2010) Rebecca R. Roberts et al. MEDICAL CARE
- Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility
- (2010) Marc H Scheetz et al. PHARMACOTHERAPY
- Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
- (2010) Elizabeth B Hirsch et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
- (2009) Rebecca R. Roberts et al. CLINICAL INFECTIOUS DISEASES
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
- (2009) Vincent H. Tam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007–2008)
- (2009) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
- (2009) Leanne B. Gasink et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital Cohort
- (2009) Anne M. Butler et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk factors and clinical features of infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae
- (2009) Yoon Soo Park et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acinetobacter: an old friend, but a new enemy
- (2009) K.J. Towner JOURNAL OF HOSPITAL INFECTION
- Clinical Features of Heteroresistant Vancomycin-IntermediateStaphylococcus aureusBacteremia versus Those of Methicillin-ResistantS. aureusBacteremia
- (2009) Yasmin Maor et al. JOURNAL OF INFECTIOUS DISEASES
- Pseudomonas aeruginosa – a phenomenon of bacterial resistance
- (2009) Tanya Strateva et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Trends in Antibacterial Use in US Academic Health Centers
- (2008) Amy L. Pakyz et al. ARCHIVES OF INTERNAL MEDICINE
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started